摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2,3-dihydroxy-propyl)-N'-[3-({3-[(2,3-dihydroxy-propyl)-methyl-carbamoyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-benzoyl}-methyl-amino)-propyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-N,N'-dimethyl-isophthalamide | 1143450-74-1

中文名称
——
中文别名
——
英文名称
N-(2,3-dihydroxy-propyl)-N'-[3-({3-[(2,3-dihydroxy-propyl)-methyl-carbamoyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-benzoyl}-methyl-amino)-propyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-N,N'-dimethyl-isophthalamide
英文别名
3-N-(2,3-dihydroxypropyl)-1-N-[3-[[3-[2,3-dihydroxypropyl(methyl)carbamoyl]-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodobenzoyl]-methylamino]propyl]-5-[(2-hydroxyacetyl)-methylamino]-2,4,6-triiodo-1-N,3-N-dimethylbenzene-1,3-dicarboxamide
N-(2,3-dihydroxy-propyl)-N'-[3-({3-[(2,3-dihydroxy-propyl)-methyl-carbamoyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-benzoyl}-methyl-amino)-propyl]-5-[(2-hydroxy-acetyl)-methyl-amino]-2,4,6-triiodo-N,N'-dimethyl-isophthalamide化学式
CAS
1143450-74-1
化学式
C35H44I6N6O12
mdl
——
分子量
1502.19
InChiKey
FMKZCTRENXSEKF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    59
  • 可旋转键数:
    18
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.49
  • 拓扑面积:
    243
  • 氢给体数:
    6
  • 氢受体数:
    12

文献信息

  • [EN] CONTRAST AGENTS<br/>[FR] AGENTS DE CONTRASTE
    申请人:GE HEALTHCARE AS
    公开号:WO2009047319A1
    公开(公告)日:2009-04-16
    The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula (I) and salts or optical active isomers thereof, wherein each R1 independently are the same or different and denotes a hydrogen atom or a C1 to C4 straight or branched alkyl group which is optionally substituted by 1 to 4 - OH groups; each of R2 independently are the same or different and denote a hydrogen atom or a C1 to C4 straight or branched alkyl group; each R3 independently are the same or different and denotes a hydrogen atom or a C1 to C4 straight or branched alkyl group which is optionally substituted by 1 to 4 - OH groups; each R4 independently are the same or different and denote C1 to C6 straight or branched alkyl moieties substituted by up to 6 -OH groups; and each R5 independently are the same or different and denote C1 to C6 straight or branched alkyl moieties substituted by up to 6 -OH groups; and X denotes a straight chain alkylene moiety with 3 to 10 carbon atoms, a 1,4- cyclohexylene group, or X together with the adjacent -NR1 groups forms a 1,4- piperazine group or a 4-aminopiperidine group. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging, and to contrast media containing such compounds.
    本发明涉及一类化合物和含有这种化合物的诊断组合物,其中这些化合物是含化合物。更具体地说,这些含化合物是化学化合物,包含有通式(I)中两个相连的化苯基团及其盐或光学活性异构体,其中每个R1独立地相同或不同,并表示氢原子或C1到C4直链或支链烷基基团,该基团可选地被1到4个-OH基取代;每个R2独立地相同或不同,并表示氢原子或C1到C4直链或支链烷基基团;每个R3独立地相同或不同,并表示氢原子或C1到C4直链或支链烷基基团,该基团可选地被1到4个-OH基取代;每个R4独立地相同或不同,并表示被高达6个-OH基取代的C1到C6直链或支链烷基基团;每个R5独立地相同或不同,并表示被高达6个-OH基取代的C1到C6直链或支链烷基基团;X表示具有3到10个碳原子的直链烷基基团,1,4-环己基基团,或X与相邻的-NR1基团一起形成1,4-哌嗪基团或4-氨基哌啶基团。本发明还涉及将这种诊断组合物用作对比剂进行诊断成像,特别是X射线成像,以及含有这种化合物的对比介质。
  • CONTRAST AGENTS
    申请人:Newington Ian Martin
    公开号:US20100221189A1
    公开(公告)日:2010-09-02
    The present invention relates to a class of compounds and to diagnostic compositions containing such compounds where the compounds are iodine containing compounds. More specifically the iodine containing compounds are chemical compounds containing two linked iodinated phenyl groups of the general formula (I) and salts or optical active isomers thereof, wherein each R 1 independently are the same or different and denotes a hydrogen atom or a C 1 to C 4 straight or branched alkyl group which is optionally substituted by 1 to 4 —OH groups; each of R 2 independently are the same or different and denote a hydrogen atom or a C 1 to C 4 straight or branched alkyl group; each R 3 independently are the same or different and denotes a hydrogen atom or a C 1 to C 4 straight or branched alkyl group which is optionally substituted by 1 to 4 —OH groups; each R 4 independently are the same or different and denote C 1 to C 6 straight or branched alkyl moieties substituted by up to 6 —OH groups; and each R 5 independently are the same or different and denote C 1 to C 6 straight or branched alkyl moieties substituted by up to 6 —OH groups; and X denotes a straight chain alkylene moiety with 3 to 10 carbon atoms, a 1,4-cyclohexylene group, or X together with the adjacent —NR 1 groups forms a 1,4-piperazine group or a 4-aminopiperidine group. The invention also relates to the use of such diagnostic compositions as contrast agents in diagnostic imaging and in particular in X-ray imaging, and to contrast media containing such compounds.
    本发明涉及一类化合物和含有这些化合物的诊断组合物,其中这些化合物是含化合物。更具体地说,这些含化合物是化学化合物,包含两个连接的化苯基团,具有一般式(I)及其盐或光学异构体,其中每个R1独立地相同或不同,表示氢原子或C1到C4直链或支链烷基,该烷基可被1到4个-OH基取代;每个R2独立地相同或不同,表示氢原子或C1到C4直链或支链烷基;每个R3独立地相同或不同,表示氢原子或C1到C4直链或支链烷基,该烷基可被1到4个-OH基取代;每个R4独立地相同或不同,表示C1到C6直链或支链烷基基团,可被多达6个-OH基取代;每个R5独立地相同或不同,表示C1到C6直链或支链烷基基团,可被多达6个-OH基取代;X表示直链烷基基团,具有3到10个碳原子,1,4-环己基基团,或X与相邻的-NR1基团一起形成1,4-哌嗪基团或4-哌嗪基团。本发明还涉及将这种诊断组合物用作对比剂进行诊断成像,特别是X射线成像,以及含有这些化合物的对比介质。
  • US8202511B2
    申请人:——
    公开号:US8202511B2
    公开(公告)日:2012-06-19
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫